Tg Therapeutics Inc (TGTX)

Tg Therapeutics Inc Azioni (TGTX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	17.28%240.34	204.92	192.57	161.71	141.15
Cost Of Revenue	22.93%41.19	33.51	38.14	28.09	18.94
	6.90%82.13	88.22	-	-	-
Selling, General, and Administrative	6.90%82.13	88.22	-	-	-
Research and Development	96.99%95.34	48.40	-	-	-
Costs And Expenses	28.53%218.66	170.12	142.08	132.34	106.31
Operating Income/Loss	37.71%21.67	34.80	50.49	29.37	34.84
Nonoperating Income/Loss	20.73%-11.44	-14.43	-5.40	-3.46	-3.92
Income/Loss From Continuing Operations Before Tax	49.74%10.23	20.36	45.09	25.91	30.92
Income Tax Expense/Benefit, Deferred	81.68%0.71	3.86	18.63	-	-
Income Tax Expense/Benefit	318.60%2.45	0.59	22.06	-364.99	2.73
	60.66%7.78	19.78	23.04	390.90	28.19
Attributable To Parent	60.66%7.78	19.78	23.04	390.90	28.19
Basic Average Shares	1.85%141.77	144.44	-1.96	145.42	146.74
Diluted Average Shares	1.74%157.28	160.06	-0.69	161.00	162.56
Basic Earnings Per Share	64.29%0.05	0.14	0.20	2.69	0.19
Diluted Earnings Per Share	58.33%0.05	0.12	0.15	2.43	0.17